{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:29:16Z","timestamp":1777350556370,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T00:00:00Z","timestamp":1510876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T00:00:00Z","timestamp":1510876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Local drug delivery systems (DDS) have become a favourable approach for the treatment of numerous diseases. Biomedical imaging techniques such as ultrahigh field magnetic resonance imaging (UHF-MRI) offer unique insight into DDS biodegradation <jats:italic>in vivo<\/jats:italic>. We describe the establishment of a 7 Tesla MRI routine for longitudinal <jats:italic>in vivo<\/jats:italic> examinations of a subconjunctival DDS for the treatment of glaucoma in a rabbit model. In initial <jats:italic>in vitro<\/jats:italic> examinations the T2-relaxation times of the polymeric DDS components were assessed. Imaging of enzymatically degraded depot samples <jats:italic>in vitro<\/jats:italic> did not reveal changes in sample morphology or T2-relaxation time. <jats:italic>Ex vivo<\/jats:italic> investigations with an enucleated porcine eye showed good correlation of anatomical MRI and histological data. In longitudinal <jats:italic>in vivo<\/jats:italic> studies in rabbits, we repeatedly scanned the depot in the same animal over the course of 5 months with an in-plane resolution of 130 \u00b5m at scan times of less than 30 minutes. The degradation was quantified using volumetric analysis showing a volume reduction of 82% between 3 and 21 weeks after depot implantation. We have thereby demonstrated the feasibility of our UHF-MRI protocol as a non-invasive imaging routine for qualitative and quantitative, longitudinal evaluation of biodegradable subconjunctival DDS.<\/jats:p>","DOI":"10.1038\/s41598-017-15954-w","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T10:30:28Z","timestamp":1510569028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Ultrahigh field MR imaging of a subconjunctival anti-glaucoma drug delivery system in a rabbit model"],"prefix":"10.1038","volume":"7","author":[{"given":"Franziska","family":"Kopp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Eickner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Polei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Falke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Witt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Grabow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Stachs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf F.","family":"Guthoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7826-3132","authenticated-orcid":false,"given":"Tobias","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,17]]},"reference":[{"key":"15954_CR1","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"Y-C Tham","year":"2014","unstructured":"Tham, Y.-C. et al. Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040. Ophthalmology \n                           121, 2081\u20132090 (2014).","journal-title":"Ophthalmology"},{"key":"15954_CR2","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","volume":"363","author":"RN Weinreb","year":"2004","unstructured":"Weinreb, R. N. & Khaw, P. T. Primary open-angle glaucoma. The Lancet \n                           363, 1711\u20131720 (2004).","journal-title":"The Lancet"},{"key":"15954_CR3","doi-asserted-by":"crossref","unstructured":"The AGIS Investigators. The advanced glaucoma intervention study (AGIS) 7. The relationship between control of intraocular pressure and visual field deterioration. Am. J. Ophthalmol. 130, 429\u2013440 (2000).","DOI":"10.1016\/S0002-9394(00)00538-9"},{"key":"15954_CR4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/ICU.0000000000000031","volume":"25","author":"OJ Knight","year":"2014","unstructured":"Knight, O. J. & Lawrence, S. D. Sustained drug delivery in glaucoma. Curr. Opin. Ophthalmol. \n                           25, 112\u2013117 (2014).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"15954_CR5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s40266-015-0282-9","volume":"32","author":"DC Broadway","year":"2015","unstructured":"Broadway, D. C. & Cate, H. Pharmacotherapy and Adherence Issues in Treating Elderly Patients with Glaucoma. Drugs Aging \n                           32, 569\u2013581 (2015).","journal-title":"Drugs Aging"},{"key":"15954_CR6","doi-asserted-by":"publisher","first-page":"410","DOI":"10.5301\/EJO.2010.6112","volume":"21","author":"GC Rossi","year":"2011","unstructured":"Rossi, G. C., Pasinetti, G. M., Scudeller, L., Radaelli, R. & Bianchi, P. E. Do adherence rates and glaucomatous visual field progression correlate? Eur. J. Ophthalmol. \n                           21, 410 (2011).","journal-title":"Eur. J. Ophthalmol."},{"key":"15954_CR7","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1016\/j.ophtha.2011.05.013","volume":"118","author":"B Sleath","year":"2011","unstructured":"Sleath, B. et al. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology \n                           118, 2398\u20132402 (2011).","journal-title":"Ophthalmology"},{"key":"15954_CR8","doi-asserted-by":"crossref","unstructured":"Caprioli, J. & Coleman, A. L. Intraocular Pressure Fluctuation: A Risk Factor for Visual Field Progression at Low Intraocular Pressures in the Advanced Glaucoma Intervention Study. Ophthalmology \n                           115, 1123\u20131129.e3 (2008).","DOI":"10.1016\/j.ophtha.2007.10.031"},{"key":"15954_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.15171\/bi.2016.07","volume":"6","author":"J Barar","year":"2016","unstructured":"Barar, J., Aghanejad, A., Fathi, M. & Omidi, Y. Advanced drug delivery and targeting technologies for the ocular diseases. Bioimpacts \n                           6, 49\u201367 (2016).","journal-title":"Bioimpacts"},{"key":"15954_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","volume":"2","author":"A Patel","year":"2013","unstructured":"Patel, A., Cholkar, K., Agrahari, V. & Mitra, A. K. Ocular drug delivery systems: An overview. World J. Pharmacol. \n                           2, 47 (2013).","journal-title":"World J. Pharmacol."},{"key":"15954_CR11","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/eye.2011.82","volume":"25","author":"E Lavik","year":"2011","unstructured":"Lavik, E., Kuehn, M. H. & Kwon, Y. H. Novel drug delivery systems for glaucoma. Eye \n                           25, 578\u2013586 (2011).","journal-title":"Eye"},{"key":"15954_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2015.06.035","volume":"214","author":"K Voss","year":"2015","unstructured":"Voss, K. et al. Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment. J. Controlled Release \n                           214, 1\u201311 (2015).","journal-title":"J. Controlled Release"},{"key":"15954_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev-chembioeng-073009-100847","volume":"1","author":"WB Liechty","year":"2010","unstructured":"Liechty, W. B., Kryscio, D. R., Slaughter, B. V. & Peppas, N. A. Polymers for Drug Delivery Systems. Annu. Rev. Chem. Biomol. Eng. \n                           1, 149\u2013173 (2010).","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"15954_CR14","doi-asserted-by":"publisher","first-page":"6575","DOI":"10.1167\/iovs.09-4865","volume":"51","author":"S Langner","year":"2010","unstructured":"Langner, S. et al. 7.1 T MRI to Assess the Anterior Segment of the Eye. Invest. Ophthalmol. Vis. Sci. \n                           51, 6575\u20136581 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"15954_CR15","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/jmri.21959","volume":"30","author":"K Richdale","year":"2009","unstructured":"Richdale, K. et al. 7 Tesla MR imaging of the human eye in vivo. J. Magn. Reson. Imaging \n                           30, 924\u2013932 (2009).","journal-title":"J. Magn. Reson. Imaging"},{"key":"15954_CR16","first-page":"2538","volume":"18","author":"L Fanea","year":"2012","unstructured":"Fanea, L. & Fagan, A. J. Review: Magnetic resonance imaging techniques in ophthalmology. Mol. Vis. \n                           18, 2538\u20132560 (2012).","journal-title":"Mol. Vis."},{"key":"15954_CR17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/jbm.b.31654","volume":"94B","author":"K Sternberg","year":"2010","unstructured":"Sternberg, K. et al. Development of a biodegradable tissue adhesive based on functionalized 1,2-ethylene glycol bis(dilactic acid). I. J. Biomed. Mater. Res. B Appl. Biomater. \n                           94B, 318\u2013326 (2010).","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"15954_CR18","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","volume":"31","author":"PA Yushkevich","year":"2006","unstructured":"Yushkevich, P. A. et al. User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability. NeuroImage \n                           31, 1116\u20131128 (2006).","journal-title":"NeuroImage"},{"key":"15954_CR19","doi-asserted-by":"publisher","first-page":"672","DOI":"10.2174\/1389450115666141122211920","volume":"16","author":"H Zhou","year":"2015","unstructured":"Zhou, H., Hernandez, C., Goss, M., Gawlik, A. & Exner, A. A. Biomedical Imaging in Implantable Drug Delivery Systems. Curr. Drug Targets \n                           16, 672\u2013682 (2015).","journal-title":"Curr. Drug Targets"},{"key":"15954_CR20","doi-asserted-by":"publisher","first-page":"OCT460","DOI":"10.1167\/iovs.16-19362","volume":"57","author":"CK Hitzenberger","year":"2016","unstructured":"Hitzenberger, C. K., Drexler, W., Leitgeb, R. A., Findl, O. & Fercher, A. F. Key Developments for Partial Coherence Biometry and Optical Coherence Tomography in the Human Eye Made in Vienna. Investig. Opthalmology Vis. Sci. \n                           57, OCT460 (2016).","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"15954_CR21","doi-asserted-by":"crossref","unstructured":"Guthoff, R. F., Labriola, L. T. & Stachs, O. Diagnostic Ophthalmic Ultrasound. in Retina Fifth Edition (ed. Ryan, S. J.) 1, 227\u2013284 (Elsevier Inc., 2012).","DOI":"10.1016\/B978-1-4557-0737-9.00009-6"},{"key":"15954_CR22","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1055\/s-0034-1383365","volume":"231","author":"T Niendorf","year":"2014","unstructured":"Niendorf, T. et al. Ophthalmological Imaging with Ultrahigh Field Magnetic Resonance Tomography: Technical Innovations and Frontier Applications. Klin. Monatsbl\u00e4tter F\u00fcr Augenheilkd. \n                           231, 1187\u20131195 (2014).","journal-title":"Klin. Monatsbl\u00e4tter F\u00fcr Augenheilkd."},{"key":"15954_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1167\/tvst.4.3.14","volume":"4","author":"M Hovakimyan","year":"2015","unstructured":"Hovakimyan, M. et al. Development of an Experimental Drug Eluting Suprachoroidal Microstent as Glaucoma Drainage Device. Transl. Vis. Sci. Technol. \n                           4, 14\u201314 (2015).","journal-title":"Transl. Vis. Sci. Technol."},{"key":"15954_CR24","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3109\/02713683.2011.587936","volume":"36","author":"R Allemann","year":"2011","unstructured":"Allemann, R. et al. Ultra High-Field Magnetic Resonance Imaging of a Glaucoma Microstent. Curr. Eye Res. \n                           36, 719\u2013726 (2011).","journal-title":"Curr. Eye Res."},{"key":"15954_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejpb.2009.06.008","volume":"74","author":"S Kempe","year":"2010","unstructured":"Kempe, S., Metz, H., Pereira, P. G. C. & M\u00e4der, K. Non-invasive in vivo evaluation of in situ forming PLGA implants by benchtop magnetic resonance imaging (BT-MRI) and EPR spectroscopy. Eur. J. Pharm. Biopharm. \n                           74, 102\u2013108 (2010).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"15954_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ejpb.2015.06.003","volume":"94","author":"A Fern\u00e1ndez-Ferreiro","year":"2015","unstructured":"Fern\u00e1ndez-Ferreiro, A. et al. In vitro and in vivo ocular safety and eye surface permanence determination by direct and Magnetic Resonance Imaging of ion-sensitive hydrogels based on gellan gum and kappa-carrageenan. Eur. J. Pharm. Biopharm. \n                           94, 342\u2013351 (2015).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"15954_CR27","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1167\/iovs.16-20694","volume":"58","author":"MB Garcia","year":"2017","unstructured":"Garcia, M. B., Jha, A. K., Healy, K. E. & Wildsoet, C. F. A Bioengineering Approach to Myopia Control Tested in a Guinea Pig Model. Invest. Ophthalmol. Vis. Sci. \n                           58, 1875\u20131886 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"15954_CR28","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.crad.2014.06.011","volume":"69","author":"J Zhao","year":"2014","unstructured":"Zhao, J. et al. Assessment of renal fibrosis in chronic kidney disease using diffusion-weighted MRI. Clin. Radiol. \n                           69, 1117\u20131122 (2014).","journal-title":"Clin. Radiol."},{"key":"15954_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.smim.2007.11.004","volume":"20","author":"JM Anderson","year":"2008","unstructured":"Anderson, J. M., Rodriguez, A. & Chang, D. T. Foreign body reaction to biomaterials. Semin. Immunol. \n                           20, 86\u2013100 (2008).","journal-title":"Semin. Immunol."},{"key":"15954_CR30","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/nbm.1230","volume":"21","author":"SK Li","year":"2008","unstructured":"Li, S. K., Lizak, M. J. & Jeong, E.-K. MRI in ocular drug delivery. NMR Biomed. \n                           21, 941\u2013956 (2008).","journal-title":"NMR Biomed."},{"key":"15954_CR31","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1167\/iovs.04-0091","volume":"45","author":"H Kim","year":"2004","unstructured":"Kim, H. et al. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging. Invest. Ophthalmol. Vis. Sci. \n                           45, 2722\u20132731 (2004).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"15954_CR32","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s10439-005-8974-7","volume":"33","author":"H Kim","year":"2005","unstructured":"Kim, H. et al. Study of Ocular Transport of Drugs Released from an Intravitreal Implant Using Magnetic Resonance Imaging. Ann. Biomed. Eng. \n                           33, 150\u2013164 (2005).","journal-title":"Ann. Biomed. Eng."},{"key":"15954_CR33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/01.iae.0000242853.80913.63","volume":"27","author":"M Jockovich","year":"2007","unstructured":"Jockovich, M., Murray, T. G., Clifford, P. D. & Moshfeghi, A. A. Posterior Juxtascleral Injection Of Anecortave Acetate: Magnetic Resonance and Echographic Imaging and Localization in Rabbit Eyes. Retina \n                           27, 247\u2013252 (2007).","journal-title":"Retina"},{"key":"15954_CR34","first-page":"112fs11","volume":"3","author":"R Robinson","year":"2011","unstructured":"Robinson, R. 3Rs of Animal Testing for Regenerative Medicine Products. Sci. Transl. Med. \n                           3, 112fs11 (2011).","journal-title":"Sci. Transl. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15954-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15954-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15954-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T13:43:42Z","timestamp":1671803022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15954-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,17]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["15954"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-15954-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,17]]},"assertion":[{"value":"2 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15780"}}